Literature DB >> 15745921

Consensus statement on the management of the GH-treated adolescent in the transition to adult care.

P E Clayton1, R C Cuneo, A Juul, J P Monson, S M Shalet, M Tauber.   

Abstract

The European Society for Paediatric Endocrinology held a consensus workshop in Manchester, UK in December 2003 to discuss issues relating to the care of GH-treated patients in the transition from paediatric to adult life. Clinicians experienced in the care of paediatric and adult patients on GH treatment, from a wide range of countries, as well as medical representatives from the pharmaceutical manufacturers of GH participated.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15745921     DOI： 10.1530/eje.1.01829

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


  56 in total

Review 1.  Growth hormone treatment in adults with growth hormone deficiency: the transition.

Authors:  M E Molitch
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

Review 2.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 3.  Transitioning of children with GH deficiency to adult dosing: changes in body composition.

Authors:  Vi Thuy Nguyen; Madhusmita Misra
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

4.  Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.

Authors:  G Aimaretti; R Attanasio; S Cannavò; M C Nicoletti; R Castello; C Di Somma; P Garofalo; L Iughetti; S Loche; M Maghnie; L Mazzanti; G Saggese; M Salerno; G Tonini; V Toscano; S Zucchini; M Cappa
Journal:  J Endocrinol Invest       Date:  2014-11-02       Impact factor: 4.256

Review 5.  Diagnosis and treatment of hypopituitarism: an update.

Authors:  M O van Aken; S W J Lamberts
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 6.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

Review 7.  [Congenital adrenal hyperplasia and growth hormone deficiency. Special care in transition to adulthood].

Authors:  H G Dörr; C Schöfl
Journal:  Internist (Berl)       Date:  2009-10       Impact factor: 0.743

8.  Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.

Authors:  Isabela Peixoto Biscotto; Valéria Aparecida Costa Hong; Rafael Loch Batista; Berenice Bilharinho Mendonca; Ivo Jorge Prado Arnhold; Luiz Aparecido Bortolotto; Luciani Renata Silveira Carvalho
Journal:  Pituitary       Date:  2020-10-24       Impact factor: 4.107

9.  Hypopituitarism induced by traumatic brain injury in the transition phase.

Authors:  G Aimaretti; M R Ambrosio; C Di Somma; M Gasperi; S Cannavò; C Scaroni; L De Marinis; R Baldelli; G Bona; G Giordano; E Ghigo
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

10.  Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin).

Authors:  Dana S Hardin
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.